Is there a predictive profile for clinical inertia in hypertensive patients?: An observational, cross-sectional, multicentre study

Drugs and Aging

Volumn 28, Issue 12, 2011, Pages 981-992

  Gil Guillén, Vicente ^a,b   Orozco Beltrán, Domingo ^a,c   Mráquez Contreras, Emilio ^d   Durazo Arvizu, Ramn ^e   Cooper, Richard ^e   Pita Fernández, Salvador ^f   González Segura, Diego ^a   Carratalá Munuera, Concepción ^a   Martín De Pablo, José Luis ^d   Pallarés, Vicente ^a   Pertusa Martínez, Salvador ^a   Fernández, Antonio ^a   Redón, Josep ^g  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b Elda Hospital   (Spain)

^c San Juan Hospital   (Spain)

^d Treatment Compliance and Inertia Research Group   (Spain)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

^f UNIVERSITY OF A CORUÑA   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTICENTER STUDY; NURSE; OBSERVATIONAL STUDY; PHARMACY; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SPAIN; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT FAILURE; YOUNG ADULT;

EID: 82455175538     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11596640-000000000-00000     Document Type: Article

References (39)

1. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001 Nov 6; 135 (9): 825-34
2. Chobanian AV, Bakris GL, Black HR, et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP; National Heart, Lung, and Blood Institute; National High BP Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP. Hypertension 2003 Dec; 42 (6): 1206-52
3. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States [published erratum appears in Arch Intern Med 2007 Apr 9; 167 (7): 648]. Arch Intern Med 2007 Jan 22; 167 (2): 141-7
4. Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich) 2000 Oct; 2 (5): 324-30
5. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of BP in a hypertensive population. N Engl J Med 1998 Dec 31; 339 (27): 1957-63
6. Julius S, Weber MA, Kjeldsen SE, et al. The ValsartanAntihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. Hypertension 2006 Sep; 48 (3): 385-91
7. Nasser SA, Lai Z, O'Connor S, et al. Does earlier attainment of BP goal translate into fewer cardiovascular events? Curr Hypertens Rep 2008 Oct; 10 (5): 398-404
8. Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 BP control goals. Hypertension 2006 Mar; 47 (3): 345-51
9. Phillips LS, Twombly JG. It's time to overcome clinical inertia. Ann Intern Med 2008 May 20; 148 (10): 783-5
10. Roumie CL, Elasy TA, Greevy R, et al. Improving BP control through provider education, provider alerts, and patient education: A cluster randomized trial. Ann Intern Med 2006 Aug 1; 145 (3): 165-75
11. Redón J, Coca A, Lázaro P, et al. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens 2010 Aug; 28 (8): 1770-7
12. Redon J, Brunner HR, Ferri C, et al. Practical solutions to the challenges of uncontrolled hypertension: A white paper. J Hypertens Suppl 2008 Dec; 26 (4): S1-14
13. Steinman MA, Fischer MA, Shlipak MG, et al. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004 Nov 15; 117 (10): 747-54
14. Oliveria SA, Lapuerta P, McCarthy BD, et al. Physicianrelated barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002 Feb 25; 162 (4): 413-20
15. Ferrari P, Hess L, Pechere-Bertschi A, et al. Reasons for not intensifying antihypertensive treatment (RIAT): A primary care antihypertensive intervention study. J Hypertens 2004 Jun; 22 (6): 1221-9
16. Márquez-ContrerasE,CocaA, de la Figuera vonWichmannM, et al., Control-Project Researchers. Cardiovascular risk profile of uncontrolled hypertensive patients: The Control- Project study. Med Clin (Barc) 2007 Jan 27; 128 (3): 86-91
17. Ferrari P. National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trial 12. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries. J Hum Hypertens 2009 Mar; 23 (3): 151-9
18. Bramlage P, Thoenes M, Kirch W, et al. Clinical practice and recent recommendations in hypertensionmanagement: Reporting a gap in a global survey of 1259 primary care physicians in 17 countries. Curr Med Res Opin 2007 Apr; 23 (4): 783-91
19. Safford MM, Shewchuk R, Qu H, et al. Reasons for not intensifying medications: differentiating ''clinical inertia'' from appropriate care. J Gen Intern Med 2007 Dec; 22 (12): 1648-55
20. Mancia G, De Backer G, Dominiczak A, et al.; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [published erratum appears in JHypertens 2007 Aug; 25 (8): 1749]. JHypertens 2007 Jun; 25 (6): 1105-87
21. O'Brien E, Asmar R, Beilin L, et al., European Society of Hypertension Working Group on BP Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home BP measurement. J Hypertens 2003 May; 21 (5): 821-48
22. Maiques Galán A, Villar Alvarez F, Brotons Cuixart C, et al.; Grupo de Prevención Cardiovascular del PAPPS. Preventive cardiovascular recommendations. Aten Primaria 2007 Nov; 39 Suppl. 3: 15-26
23. Gil-Guillén V, Orozco-Beltrán D, Pérez RP, et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press 2010 Feb; 19 (1): 3-10
24. Lü ders S, Schrader J, Schmieder RE, et al. Improvement of hypertension management by structured physician education and feedback system: Cluster randomized trial. Eur J Cardiovasc Prev Rehabil 2010 Jun; 17 (3): 271-9
25. Cushman WC, Ford CE, Cutler JA, et al., ALLHAT Collaborative Research Group. Success and predictors of BP control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002 Nov-Dec; 4 (6): 393-404
26. Mancia G, Laurent S, Agabiti-Rosei E, et al., European Society of Hypertension. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 2009 Nov; 27 (11): 2121-58
27. Vasan RS, Larson MG, Leip EP, et al. Impact of highnormal BP on the risk of cardiovascular disease. N Engl J Med 2001 Nov 1; 345 (18): 1291-7
28. Lewington S, Clarke R, Qizilbash N, et al., Prospective Studies Collaboration. Age-specific relevance of usual BP to vascular mortality: Ameta-analysis of individual data for one million adults in 61 prospective studies [published erratum appears in Lancet 2003 Mar 22; 361 (9362): 1060]. Lancet 2002 Dec 14; 360 (9349): 1903-13
29. Arguedas JA, Perez MI, Wright JM. Treatment BP targets for hypertension. Cochrane Database Syst Rev 2009 Jul 8; (3): CD004349
30. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998 May 21; 338 (21): 1516-20
31. Parchman ML, Pugh JA, Romero RL, et al. Competing demands or clinical inertia: The case of elevated glycosylated hemoglobin. Ann Fam Med 2007 May-Jun; 5 (3): 196-201
32. Llisterri Caro JL, Rodríguez Roca GC, Alonso Moreno FJ, et al.; Grupo de Trabajo de Hipertension Arterial de la Sociedad Españ ola de Medicina Rural y Generalista (Grupo HTA/SEMERGEN); Investigadores del Estudio PRESCAP 2002. BP control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study [in Spanish]. Med Clin (Barc) 2004 Feb 14; 122 (5): 165-71
33. Rodríguez Roca GC, Artigao Ródenas LM, Llisterri Caro JL, et al. Control of hypertension in elderly patients receiving primary care in Spain. Rev Esp Cardiol 2005 Apr; 58 (4): 359-66
34. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999 Oct 20; 282 (15): 1458-65
35. Jamerson K,Weber MA, Bakris GL, et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008 Dec 4; 359 (23): 2417-28
36. Glynn LG, Murphy AW, Smith SM, et al. Interventions used to improve control of BP in patients with hypertension. Cochrane Database Syst Rev 2010 Mar 17; (3): CD005182
37. Gorostidi M, Sobrino J, Segura J, et al., Spanish Society of Hypertension ABPM Registry Investigators. Ambulatory BP monitoring in hypertensive patients with high cardiovascular risk: A cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens 2007 May; 25 (5): 977-84
38. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, et al. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann InternMed 2008 May 20; 148 (10): 717-27
39. Howes F, Hansen E, Williams D, et al. Barriers to diagnosing and managing hypertension-a qualitative study in Australian general practice. Aust Fam Physician 2010 Jun- Jul; 39 (6): 511-6